Acquisition opportun DCT was acquired by Linus Health in early 2020, with the DCTclock assessment subsequently aligning under Linus Health. This presents a potential channel to engage Linus Health’s sales ecosystem for ongoing licensing, integration, or co-selling opportunities.

Low HCP footprint Small team size (2-10 employees) suggests a lean operation with limited direct sales capacity. Targeted outreach to decision-makers within Linus Health or potential acquirers may yield higher conversion efficiency and faster partner enablement.

Fast to deploy The test is non-invasive, inexpensive, and delivers instant results in under 2 minutes, with minimal counter space. This makes it suitable for adoption in clinics, telemedicine, or primary care settings seeking rapid cognitive screening solutions.

Clinical provenance Development history at MIT and Lahey Hospital with Framingham normative data underscores credibility. Use this to position the solution for hospital systems and larger diagnostics players seeking validated cognitive assessment tools.

Affiliates & data Tech stack indicates cloud and analytics readiness (AWS, Google Analytics) and potential for data-driven partnerships. Explore opportunities with healthcare IT vendors, EHR/LIS integrators, and research institutes seeking AI-based cognitive metrics.